Propylthiouracil

Propylthiouracil

SCHEMBL2322792

CCCc1cc(=O)[nH]c(=S)[nH]1.NCC(=O)O

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DIO1TPO

The experimentally established mechanism targets of Propylthiouracil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TPO known ✓ P07202 1/20 0.76
CYP2C19 P33261 2/20 0.76
LPO P22079 2/20 0.76
MPO P05164 1/20 0.76
TSHR P16473 1/20 0.76
TAS2R38 P59533 1/20 0.76
KMT2A Q03164 1/20 0.60
MAPT P10636 1/20 0.47
ALDH1A1 P00352 2/20 0.46
CYB5R3 P00387 2/20 0.46
CYP3A4 P08684 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
GPR84 Q9NQS5 10/20 0.40
PTGS1 P23219 1/20 0.40
BAZ2B Q9UIF8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylthiouracil SCHEMBL41239 0.87 LPO (1.00) CYP2C19LPOMPOTPOTSHR
Propylthiouracil SCHEMBL5493716 0.87 LPO (1.00) CYP2C19LPOMPOTPOTSHR
Propylthiouracil SCHEMBL2323413 0.80 CYP2C19 (0.58) CYP2C19LPOMPOTPOTSHR
Propylthiouracil SCHEMBL13723721 0.80 LPO (0.83) CYP2C19LPOMPOTPOTSHR
SCHEMBL8407853 0.77 KMT2A (0.90) CYP2C19LPOMPOTPOTSHR
SCHEMBL141453 0.76 KMT2A (0.61) CYP2C19LPOMPOTPOTSHR
SCHEMBL10489579 0.76 KMT2A (1.00) CYP2C19LPOMPOTPOTSHR
Propylthiouracil SCHEMBL20771755 0.75 LPO (0.73) CYP2C19LPOMPOTPOTSHR
SCHEMBL11739128 0.74 KMT2A (0.97) CYP2C19LPOMPOTPOTSHR
SCHEMBL15752987 0.74 KMT2A (0.97) CYP2C19LPOMPOTPOTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3362071-A1 CRYSTALLIZATION METHOD AND BIOAVAILABILITY Grünenthal GmbH (DE) 2018-08-22 EP disclosed
WO-2017049294-A1 CRYSTALLIZATION METHOD AND BIOAVAILABILITY THAR PHARMACEUTICALS, INC. (US) 2017-03-23 WO disclosed
WO-2011097269-A9 CRYSTALLIZATION METHOD AND BIOAVAILABILITY THAR PHARMACEUTICALS, INC. (US) 2012-12-27 WO disclosed
EP-2531200-A1 CRYSTALLIZATION METHOD AND BIOAVAILABILITY Thar Pharmaceuticals, Inc. (US) 2012-12-12 EP disclosed
WO-2011097269-A1 CRYSTALLIZATION METHOD AND BIOAVAILABILITY THAR PHARMACEUTICALS, INC. (US) 2011-08-11 WO disclosed